<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>81(4)</volume><submitter>Moon JY</submitter><pubmed_abstract>A &lt;i>Salmonella&lt;/i> Typhimurium ghost vaccine was constructed with the use of a recombinant fusion protein consisting of lysozyme and porcine myeloid antimicrobial peptide 36 expressed by the &lt;i>Escherichia coli&lt;/i> overexpression system. After confirmation of its effectiveness by transmission electron microscopy the vaccine was evaluated in a murine model. Of the 60 BALB/c mice equally divided into 4 groups, group A mice were intramuscularly inoculated with 100 μL of sterile phosphate-buffered saline, and the mice in groups B, C, and D were intramuscularly inoculated with approximately 1.0 × 10&lt;sup>4&lt;/sup>, 1.0 × 10&lt;sup>5&lt;/sup>, or 1.0 × 10&lt;sup>6&lt;/sup> cells of the &lt;i>S.&lt;/i> Typhimurium ghost vaccine, respectively, in 100-μL amounts. The serum IgG titers against &lt;i>S.&lt;/i> Typhimurium oute</pubmed_abstract><journal>Canadian journal of veterinary research = Revue canadienne de recherche veterinaire</journal><pagination>297-303</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5644453</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Protective efficacy of a &lt;i>Salmonella&lt;/i> Typhimurium ghost vaccine candidate constructed with a recombinant lysozyme-PMAP36 fusion protein in a murine model.</pubmed_title><pmcid>PMC5644453</pmcid><pubmed_authors>Kim WK</pubmed_authors><pubmed_authors>Mun JY</pubmed_authors><pubmed_authors>Kim SY</pubmed_authors><pubmed_authors>Hur J</pubmed_authors><pubmed_authors>Kim B</pubmed_authors><pubmed_authors>Park JH</pubmed_authors><pubmed_authors>Moon JY</pubmed_authors><pubmed_authors>Choi HS</pubmed_authors><pubmed_authors>Rao Z</pubmed_authors></additional><is_claimable>false</is_claimable><name>Protective efficacy of a &lt;i>Salmonella&lt;/i> Typhimurium ghost vaccine candidate constructed with a recombinant lysozyme-PMAP36 fusion protein in a murine model.</name><description>A &lt;i>Salmonella&lt;/i> Typhimurium ghost vaccine was constructed with the use of a recombinant fusion protein consisting of lysozyme and porcine myeloid antimicrobial peptide 36 expressed by the &lt;i>Escherichia coli&lt;/i> overexpression system. After confirmation of its effectiveness by transmission electron microscopy the vaccine was evaluated in a murine model. Of the 60 BALB/c mice equally divided into 4 groups, group A mice were intramuscularly inoculated with 100 μL of sterile phosphate-buffered saline, and the mice in groups B, C, and D were intramuscularly inoculated with approximately 1.0 × 10&lt;sup>4&lt;/sup>, 1.0 × 10&lt;sup>5&lt;/sup>, or 1.0 × 10&lt;sup>6&lt;/sup> cells of the &lt;i>S.&lt;/i> Typhimurium ghost vaccine, respectively, in 100-μL amounts. The serum IgG titers against &lt;i>S.&lt;/i> Typhimurium oute</description><dates><release>2017-01-01T00:00:00Z</release><publication>2017 Oct</publication><modification>2025-06-01T03:24:19.624Z</modification><creation>2021-02-20T02:02:22Z</creation></dates><accession>S-EPMC5644453</accession><cross_references><pubmed>29081588</pubmed></cross_references></HashMap>